A study by the German Low Grade Lymphoma Study Group has shown that rituximab maintenance following salvage with rituximab-containing chemotherapy is the standard of care for advanced-stage refractory or relapsed follicular lymphoma.
Related Articles
Senza categoria
Newsround
Impact Factor
Rituximab for follicular lymphoma: maintaining an open mind
Impact Factor